首页> 外文期刊>Journal of human genetics >Detecting copy-number variations in whole-exome sequencing data using the eXome Hidden Markov Model: an 'exome-first' approach
【24h】

Detecting copy-number variations in whole-exome sequencing data using the eXome Hidden Markov Model: an 'exome-first' approach

机译:使用eXome隐藏式马尔可夫模型检测全外显子测序数据中的拷贝数变异:“外显子优先”方法

获取原文
获取原文并翻译 | 示例
           

摘要

Whole-exome sequencing (WES) is becoming a standard tool for detecting nucleotide changes, and determining whether WES data can be used for the detection of copy-number variations (CNVs) is of interest. To date, several algorithms have been developed for such analyses, although verification is needed to establish if they fit well for the appropriate purpose, depending on the characteristics of each algorithm. Here, we performed WES CNV analysis using the eXome Hidden Markov Model (XHMM). We validated its performance using 27 rare CNVs previously identified by microarray as positive controls, finding that the detection rate was 59%, or higher (89%) with three or more targets. XHMM can be effectively used, especially for the detection of 4200 kb CNVs. XHMM may be useful for deletion breakpoint detection. Next, we applied XHMM to genetically unsolved patients, demonstrating successful identification of pathogenic CNVs: 1.5-1.9-Mb deletions involving NSD1 in patients with unknown overgrowth syndrome leading to the diagnosis of Sotos syndrome, and 6.4-Mb duplication involving MECP2 in affected brothers with late-onset spasm and progressive cerebral/cerebellar atrophy confirming the clinical suspect of MECP2 duplication syndrome. The possibility of an 'exome-first' approach for clinical genetic investigation may be considered to save the cost of multiple investigations.
机译:全外显子测序(WES)成为检测核苷酸变化的标准工具,确定WES数据是否可用于检测拷贝数变异(CNV)成为人们关注的问题。迄今为止,已经开发了用于这种分析的几种算法,尽管需要进行验证来确定它们是否适合于适当的目的,具体取决于每种算法的特性。在这里,我们使用eXome隐藏Markov模型(XHMM)进行了WES CNV分析。我们使用先前通过微阵列鉴定为阳性对照的27种罕见CNV验证了其性能,发现三个或更多靶标的检出率为59%或更高(89%)。 XHMM可以有效地使用,尤其是用于检测4200 kb CNV。 XHMM对于删除断点检测可能很有用。接下来,我们将XHMM应用于尚未解决遗传问题的患者,证明成功鉴定了致病性CNV:未知过度生长综合征患者中涉及NSD1的1.5-1.9-Mb缺失导致Sotos综合征的诊断,以及患有MECP2的受影响兄弟中6.4-Mb复制迟发性痉挛和进行性脑/小脑萎缩证实了MECP2复制综合征的临床怀疑。可以考虑采用“外显优先”方法进行临床遗传研究的方法,以节省多次研究的费用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号